Klem,
Clearly you don't read too many financial reports. The lines:
"The directors have reasonable ground to believe the inclusion of other information regarding likely developments of the company and
expected results of those actions would be unreasonably prejudicial to the company because of there confidential nature"
are almost word for word what you will find in thousands of annual reports written every year.
- Forums
- ASX - By Stock
- CST
- annual report
annual report, page-3
Featured News
Add CST (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.7¢ |
Change
-0.006(6.45%) |
Mkt cap ! $21.04M |
Open | High | Low | Value | Volume |
9.3¢ | 9.3¢ | 8.7¢ | $6.006K | 67.75K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11660 | 8.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.4¢ | 40000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11660 | 0.087 |
1 | 24000 | 0.084 |
1 | 25000 | 0.080 |
1 | 15857 | 0.078 |
1 | 50000 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.094 | 40000 | 1 |
0.095 | 31578 | 1 |
0.100 | 50000 | 1 |
0.110 | 20607 | 1 |
0.125 | 35001 | 1 |
Last trade - 11.28am 12/11/2024 (20 minute delay) ? |
Featured News
CST (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online